Gleneagles Hospital HK forms strategic partnership to advance venous disease care

It will explore the use of AI to improve diagnosis and treatment.

Gleneagles Hospital Hong Kong, part of the IHH Healthcare network, has partnered with the Asian Venous Academy and Dr Smile Medical Group to advance clinical practice, medical education, and innovation in venous disease.

The collaboration will also explore the use of artificial intelligence to improve diagnosis and treatment.

Dr Kenneth Tsang, CEO of Gleneagles Hospital Hong Kong, said the partnership will use Hong Kong’s clinical research strengths to expand medical technologies, therapies, and expertise from Chinese Mainland companies globally.

The initiative will support academic exchange, multidisciplinary collaboration, and enhanced patient care across the region.